IRF2BP2 and neoplasm: Consistently, H.E. staining and immunohistochemical analysis for Ki67 and c‐Myc demonstrated reduced tumor infiltration in the liver, spleen, and bone marrow following IRF2BP2 knockdown (Figure 4I,J; Figure S10A–E, Supporting Information).